CSRxP: HELP Preview Biosimilar Fact Sheet
Jun 16, 2026
Several bipartisan, market-based solutions that would help foster greater… Read More
© 2026 CSRXP- All Rights Reserved
Resources
CSRxP: HELP Markup Fact Sheet
Jun 12, 2026
How Congress Can Lower Drug Prices, Boost Competition Trio of Bipartisan… Read More
CSRxP: Myth vs. Fact
Jun 11, 2026
Brand name drug manufacturers game the patent system and drug approval process… Read More
CSRxP: Innovation
May 29, 2026
For far too long, Big Pharma has used the false excuse that research and… Read More
CSRxP: Statement for the Record
Feb 10, 2026
Committee Chairman Guthrie, Committee Ranking Member Pallone, Subcommittee… Read More
CSRxP: Affordability
Jan 20, 2026
Big Pharma’s egregious pricing and anti-competitive practices are… Read More
CSRxP: Margin Analysis
Jan 13, 2026
Pharmaceutical manufacturers’ profit margins are 10 times larger than other… Read More
Fact Sheet: Biosimilar Competition
Apr 7, 2025
Big Pharma deploys a full suite of tactics designed to game the U.S. patent… Read More
Fact Sheet: Patent Abuse
Apr 2, 2025
Big Pharma has a long history of price-gouging American patients… Read More
CSRxP: Margin Analysis
Nov 20, 2024
Pharmaceutical manufacturers’ average annual net income margin is higher… Read More
CSRxP Biosimilar Competition Fact Sheet
May 2, 2024
Big Pharma deploys a full suite of tactics designed to game the U.S. Read More
Fact Sheet: Big Pharma Brings Insulin Price-Gouging Playbook To Blockbuster Weight Loss Drugs
Dec 13, 2023
As 2023 comes to a close, one of the biggest stories in the drug pricing space… Read More